Stanford Medicine Study Identifies Biomarker for Chronic Fatigue Syndrome

May 12, 2019 | Biomarker, Blood Test, Chronic Fatigue Syndrome, Stanford

Chronic Fatigue Syndrome

Hanae Armitage writing for Stanford Medicine News reports a Stanford research team has formulated a new blood-based test that accurately identifies individuals with chronic fatigue syndrome. Presently, there is no scientific proof for chronic fatigue disease but thanks to a Stanford team led by Ron Davis, that may change soon. They have created a blood test that can flag the disease which presently lacks a standard, reliable diagnostic test.

The research team devised a test, still in a pilot phase, based on how an individual’s immune cells respond to stress.  The team organized the study around 40 blood samples; 20 with chronic fatigue and 20 without.  Researchers found  the test produced accurate results—flagging all chronic fatigue syndrome patients and none of the healthy individuals. This is an important breakthrough; it can be a debilitating disease with high personal and societal costs. It is estimated that up to 2.5 million in American are afflicted with the disease according to the CDC.  Follow the link to the source for more important details.  This important study was funded by the Open Medicine Society.

Lead Research/Investigator

Ron Davis, PhD, professor of biochemistry & genetics

Rahim Esfandyarpour, assistant professor



Pin It on Pinterest